🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has removed violative material and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Online Trading Operations

Research also found groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.

After moments of entering one community, a vendor shared contact information, where most purchases take place. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these communities, posts show dark colored packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to potentially significant health risks”.